IP Library Granted Patent US 8,304,441
Granted Patent B2
US 8,304,441 · App. 13/279,657 · Granted Nov 6, 2012

Thiazolidinedione analogues for the treatment of metabolic diseases

Assignee: Metabolic Solutions Development Company, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,304,441
App. No.
13/279,657
Granted
Nov 6, 2012
Kind
B2
Abstract

The present invention relates to thiazolidinedione analogues that are useful for treating hypertension, diabetes, and inflammatory diseases.

Claims (11)

1. A method of treating diabetes comprising administering to a patient in need thereof a compound selected from

or a pharmaceutically acceptable salt thereof.

2. The method of claim 1 , wherein the diabetes being treated is type-2 diabetes.

3. The method of claim 1 , wherein the diabetes being treated is type-1 diabetes.

4. A method of treating diabetes comprising administering to a patient in need thereof a pharmaceutical composition comprising a compound selected from

or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

5. The method of claim 4 , wherein the pharmaceutical composition further comprises a DPP-4 inhibitor.

6. The method of claim 5 , wherein the DPP-4 inhibitor is selected from sitagliptin, vildagliptin, or any combination thereof.

7. The method of claim 4 , wherein the pharmaceutical composition further comprises a GLP-1 agonist, a GLP-2 agonist, or any combination thereof.

8. The method of claim 4 , wherein the pharmaceutical composition further comprises a statin.

9. The method of claim 8 , wherein the statin is selected from atorvastatin, cerivastatin, fluvastatin, lovastatin, mevastatin, simvastatin, rosuvastatin, pravastatin, or any combination thereof.

Assignments (5)
CHANGE OF NAME Recorded May 12, 2017
From: OCTETA THERAPEUTICS, LLC
To: CIRIUS THERAPEUTICS, INC.
Reel/Frame 042457/0520 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2016
From: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
To: OCTETA THERAPEUTICS, LLC
Reel/Frame 038996/0394 →
RELEASE OF SECURITY INTEREST Recorded May 19, 2016
From: PACIFIC WESTERN BANK (AS SUCCESSOR IN INTEREST BY MERGER TO SQUARE 1 BANK)
To: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
Reel/Frame 038652/0097 →
SECURITY AGREEMENT Recorded Feb 5, 2014
From: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
To: SQUARE 1 BANK
Reel/Frame 032162/0330 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2012
From: COLCA, GERARD R.; GADWOOD, ROBERT C.; PARKER, TIM
To: METABOLIC SOLUTIONS DEVELOPMENT COMPANY
Reel/Frame 027768/0262 →
Continuity (3)
Division 12677541
Provisional Application 60972639 · Sep 14, 2007
Related Publication 20120129896A1 · May 24, 2012